General Information of the Compound
Compound ID
CP0402926
Compound Name
6-(3-fluorophenyl)-4-methyl-1,4-dihydro-3,1-benzoxazine-2-thione
    Show/Hide
Structure
Formula
C15H12FNOS
Molecular Weight
273.332
Canonical SMILES
CC1OC(=S)Nc2ccc(cc12)-c1cccc(F)c1
    Show/Hide
InChI
InChI=1S/C15H12FNOS/c1-9-13-8-11(10-3-2-4-12(16)7-10)5-6-14(13)17-15(19)18-9/h2-9H,1H3,(H,17,19)
    Show/Hide
InChIKey
NAQUDAIOMWNXJF-UHFFFAOYSA-N
Physicochemical Property
logP
4.2807
Rotatable Bonds
1
Heavy Atom Count
19
Polar Areas
21.26
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10423425
SID: 15442176
ChEMBL ID
CHEMBL24913
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01172, Progesterone receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000078 T-47D Homo sapiens (Human)  1
1
EC50 = 300 nM
   TI
   LI
   LO
   TS